ES2913298T5 - Pct and pro-adm as markers for monitoring antibiotic treatment - Google Patents
Pct and pro-adm as markers for monitoring antibiotic treatmentInfo
- Publication number
- ES2913298T5 ES2913298T5 ES18765658T ES18765658T ES2913298T5 ES 2913298 T5 ES2913298 T5 ES 2913298T5 ES 18765658 T ES18765658 T ES 18765658T ES 18765658 T ES18765658 T ES 18765658T ES 2913298 T5 ES2913298 T5 ES 2913298T5
- Authority
- ES
- Spain
- Prior art keywords
- sample
- proadm
- level
- fragment
- pct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17190913 | 2017-09-13 | ||
| PCT/EP2018/074724 WO2019053117A1 (en) | 2017-09-13 | 2018-09-13 | PCT AND PRO-ADM USED AS CONTROL MARKERS IN ANTIBIOTIC TREATMENT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2913298T3 ES2913298T3 (es) | 2022-06-01 |
| ES2913298T5 true ES2913298T5 (en) | 2026-01-02 |
Family
ID=59887051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18765658T Active ES2913298T5 (en) | 2017-09-13 | 2018-09-13 | Pct and pro-adm as markers for monitoring antibiotic treatment |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200264199A1 (https=) |
| EP (2) | EP3682241B2 (https=) |
| JP (2) | JP7258860B2 (https=) |
| CN (1) | CN111094981B (https=) |
| BR (1) | BR112020004150A2 (https=) |
| CA (1) | CA3075442C (https=) |
| DK (1) | DK3682241T4 (https=) |
| ES (1) | ES2913298T5 (https=) |
| WO (1) | WO2019053117A1 (https=) |
| ZA (1) | ZA202001108B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111094981B (zh) | 2017-09-13 | 2024-04-16 | B.R.A.H.M.S有限公司 | Pct和pro-adm作为监测抗生素治疗的标记物 |
| RU2724186C1 (ru) * | 2020-01-23 | 2020-06-22 | Наталья Борисовна Гусева | Способ лечения детей раннего возраста с рецидивирующей инфекцией мочевой системы |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2570703B1 (fr) | 1984-09-26 | 1988-07-08 | Commissariat Energie Atomique | Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents |
| US4882733A (en) | 1987-03-13 | 1989-11-21 | Ford Aerospace Corporation | Method and apparatus for combining encoding and modulation |
| FR2664699B1 (fr) | 1990-07-13 | 1995-08-18 | Cis Bio Int | Procede d'amplification du signal d'emission d'un compose luminescent. |
| CN103123359B (zh) * | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| JP5989965B2 (ja) * | 2008-01-08 | 2016-09-07 | メルク シャープ エンド ドーム リミテッド | ２−｛４−［（３ｓ）−ピペリジン−３−イル］フェニル｝−２ｈ−インダゾール−７−カルボキサミドの薬学的に許容される塩 |
| EP2438447B1 (en) | 2009-06-05 | 2015-02-18 | B.R.A.H.M.S GmbH | Detection of bacterial infections in subjects suffering from dyspnea. |
| EP2545379B1 (en) * | 2010-03-08 | 2015-09-30 | B.R.A.H.M.S GmbH | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints |
| WO2012059477A1 (en) * | 2010-11-01 | 2012-05-10 | B.R.A.H.M.S Gmbh | Prognosis and risk assessment of patients with non-specific complaints |
| US11067586B2 (en) * | 2011-11-16 | 2021-07-20 | Sphingotec Gmbh | Adrenomedullin assays and methods for determining mature adrenomedullin |
| EP2637023A1 (en) * | 2012-03-08 | 2013-09-11 | B.R.A.H.M.S GmbH | Prediction of outcome in patients with chronic obstructive pulmonary disease |
| EP2976646B1 (en) * | 2013-03-20 | 2020-08-19 | sphingotec GmbH | Adrenomedullin to guide therapy of blood pressure decline |
| CN111094981B (zh) | 2017-09-13 | 2024-04-16 | B.R.A.H.M.S有限公司 | Pct和pro-adm作为监测抗生素治疗的标记物 |
-
2018
- 2018-09-13 CN CN201880059114.XA patent/CN111094981B/zh active Active
- 2018-09-13 WO PCT/EP2018/074724 patent/WO2019053117A1/en not_active Ceased
- 2018-09-13 DK DK18765658.2T patent/DK3682241T4/da active
- 2018-09-13 EP EP18765658.2A patent/EP3682241B2/en active Active
- 2018-09-13 CA CA3075442A patent/CA3075442C/en active Active
- 2018-09-13 JP JP2020515656A patent/JP7258860B2/ja active Active
- 2018-09-13 EP EP22159272.8A patent/EP4027145A1/en active Pending
- 2018-09-13 US US16/646,799 patent/US20200264199A1/en active Pending
- 2018-09-13 BR BR112020004150-5A patent/BR112020004150A2/pt unknown
- 2018-09-13 ES ES18765658T patent/ES2913298T5/es active Active
-
2020
- 2020-02-21 ZA ZA2020/01108A patent/ZA202001108B/en unknown
-
2023
- 2023-04-05 JP JP2023061326A patent/JP2023095851A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111094981B (zh) | 2024-04-16 |
| ZA202001108B (en) | 2022-08-31 |
| CA3075442C (en) | 2024-04-02 |
| EP3682241A1 (en) | 2020-07-22 |
| EP4027145A1 (en) | 2022-07-13 |
| RU2020111718A3 (https=) | 2022-02-01 |
| WO2019053117A1 (en) | 2019-03-21 |
| RU2020111718A (ru) | 2021-10-13 |
| EP3682241B2 (en) | 2025-09-10 |
| US20200264199A1 (en) | 2020-08-20 |
| JP7258860B2 (ja) | 2023-04-17 |
| DK3682241T4 (da) | 2025-10-06 |
| JP2020533603A (ja) | 2020-11-19 |
| DK3682241T3 (da) | 2022-05-16 |
| ES2913298T3 (es) | 2022-06-01 |
| CN111094981A (zh) | 2020-05-01 |
| CA3075442A1 (en) | 2019-03-21 |
| EP3682241B1 (en) | 2022-03-30 |
| WO2019053117A8 (en) | 2021-01-21 |
| BR112020004150A2 (pt) | 2020-09-08 |
| JP2023095851A (ja) | 2023-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025019061A (ja) | 術後有害事象の診断または予後 | |
| JP7579353B2 (ja) | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン | |
| JP2024091650A (ja) | 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ | |
| US20250189539A1 (en) | Sample including pro-adm as a therapy monitoring marker for critcally ill patients | |
| JP2024023615A (ja) | 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ | |
| US20240393352A1 (en) | Antibiotic therapy guidance based on procalcitonin in patients with comorbidities | |
| JP2023095851A (ja) | 抗生物質治療をモニタリングするためのマーカーとしてのｐｃｔおよびｐｒｏ－ａｄｍ | |
| ES2909399T3 (es) | Proadrenomedulina como marcador de niveles anormales de plaquetas | |
| RU2782305C2 (ru) | Про-адм в качестве маркера мониторинга терапии для критически больных пациентов | |
| RU2788885C2 (ru) | Прокальцитонин и про-адм в качестве маркеров для мониторинга лечения антибиотиками | |
| HK40077959A (en) | Pro-adm for therapy monitoring of intensive care unit patients | |
| RU2820944C2 (ru) | Проадм для прогнозирования риска состояния, требующего госпитализации, у пациентов с симптомами инфекционного заболевания | |
| HK40031519B (en) | Pct and pro-adm as markers for monitoring antibiotic treatment |